Академический Документы
Профессиональный Документы
Культура Документы
κ δ
µ
Analgesia (spinal level) Proconvulsant action
Dysphoria
µ1 µ2 Psychotomimetic effect
Resp. depression
Analgesia
(supra spinal)
Analgesia(spinal)
Euphoria
Resp. Depression
Dependence
Inhibition of GI motility
Opioid agonists- Morphine
M.O.A-acts through µ, δ , k receptors.
Location- spinal, supraspinal & peripheral nerves.
I) CNS-
1.Analgesia-potent analgesic
• Mediates through µ(spinal & supraspinal) receptors.
• Raises pain threshold levels & tolerability.
• Dull aching pain < sharp pricking pain.
• Higher doses- relieves sever pain.
• Alters both perception & reaction to pain.
• Alters emotional reaction to pain.
• Sedation & euphoria contribute for analgesic effect.
2.Euphoria, sedation & Hypnosis-
• Euphoria- sense of well being.
-Responsible for drug abuse.
• Rapid I.V inj- warm flushing of skin & pleasurable
sensation in lower abdomen- known as high, rush & Kick.
• Loss of rational thinking & have day dreams.
• Drowsiness, calming, inability to concentrate.
• Felling of detachment & indifference to surroundings.
• These effects may not be pleasurable to all.
• Person has to learn to perceive pleasurable effects.
3.Respiration-
• Directly depress the resp. centre dose dependently.
• Depress all phases of resp. ( rate & tidal volume).
• Causes irregular & periodic breathing.
• In poisoning- death due to resp. arrest.
• Sedation adds up.
4) Cough- directly depress the cough centre.
• Its an antitussive.
5) Nausea & emesis-
• Directly + CTZ N & V.
• High dose – Vc = No emesis in poisoning.
• Emetics shouldn't use in morphine poisoning.
6) Pupils-
• Miosis- central effect.
• High dose- pinpoint pupil.
7) Vagus - + vagal centre bradycardia.
8) Heat regulation- body temperature falls.
9) Excitatory effect- high doses convulsions.
II) PNS Effects-
2.Opioid maintenance-
- Increase oral dose to produce tolerance. Such pt’s don’t
experience the pleasurable effects on I.V morphine.
- So pt give up the habit because of methadone tolerance.
Pentazocine -
• Its opioid agonist- antagonist.
• Agonistic to k & week antagonistic to µ R.
Pharmacological actions-
• CNS effects are similar to morphine.
• Sedation & Resp -- are less.
• Tolerance & dependence- repeated use.
• Euphoria – low doses.
• High doses-Dysphoria, hallucination & nightmares.
• CVS- HR, B.P, due to sympathetic + - cardiac work.
C.I- pt’s with HTN, IHD,MI.
Dose- 50-100mg orally , 30-60mg I.M
Uses- P.O.P & chronic pain due to less abuse liability.
Nalbuphine - agonist & antagonist.
•More potent than pentazocine
•Good analgesic.
•Resp. depression only at low dose & not above 30mg.
•High doses- dysphoria.
•Analgesic dose- 10-20mg IM
Buprenorphine- Thebaine.
• Partial receptor µ agonist
• 25-50 times > morphine.
• Actions are similar to morphine.
• Has delayed onset & prolong action.
• Tolerance & dependence – less.
• Withdrawal syndrome appears late & is mild.
Routes- S.L/ I.M/ I.V.
Uses-
• P.O.P, Myocardial & cancer pain
• As a maintenance therapy in opioid addicts.
Note-it induces resp-- is not completely reversed by Naloxone.
• So its not used in labour pain.
Nalorphine - agonist & antagonist
• Low dose- good analgesic.
• Low dose - dysphoria & resp. depression.
• So it can’t be used a analgesic.
• High doses- act as a antagonist & reverse all the actions of
opioids.
Uses- A/C opioid poisoning.
- diagnosis of opioid addiction.
Opioid antagonists
Thalamus
Descending
modulation
pathway
Brain stem
Spinal cord
Peripheral stimulus
Ca2+ Ca2+
Opioid
opioid
receptor
Primary
afferent
nociceptor
terminal
Neurotransmitter
Opioid
glutamate
opioid
receptor
Secondary
ascending K+ K+
neuron
Primary opioid
afferent receptor
nociceptor
terminal
Neurotransmitter
glutamate
opioid
receptor
Secondary
ascending K+ K+
neuron
Mu Delta Kappa
Morphine, +++ + +
Codeine
Methadone ++ - -
Pethidine ++ + +
Pentazocine + + ++
Buprenorphine +++ - ++
Naloxone +++ + ++
Naltrexone +++ + +++
Agonist + Antagonist +
Mu and Kappa Receptor Activation
Analgesia
Respiratory
Depression
Euphoria
Dysphoria
Decrease GI
motility
Physical
Dependence
Withdrawl Reactions
Acute Action Withdrawl Sign
• Analgesia • Pain and irritability
• Respiratory Depression • Hyperventilation
• Euphoria • Dysphoria and depression
• Relaxation and sleep • Restlessness and insomnia
• Tranquilization • Fearfulness and hostility
• Decreased blood pressure • Increased blood pressure
• Constipation • Diarrhea
• Pupillary constriction • Pupillary dilation
• Hypothermia • Hyperthermia
• Drying of secretions • Lacrimation, runny nose
• Reduced sex drive • Spontaneous ejaculation
• Flushed and warm skin • Chilliness and “gooseflesh”